Dermatofibroma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
m Bot: Removing from Primary care |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are no established measures for the | There are no established measures for the [[secondary prevention]] of dermatofibroma. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
There are no established measures for the | There are no established measures for the [[secondary prevention]] of dermatofibroma. | ||
==References== | ==References== | ||
| Line 26: | Line 15: | ||
{{WS}} | {{WS}} | ||
| |||
[[Category:Medicine]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
Latest revision as of 21:18, 29 July 2020
|
Dermatofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatofibroma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Dermatofibroma secondary prevention |
|
Risk calculators and risk factors for Dermatofibroma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There are no established measures for the secondary prevention of dermatofibroma.
Secondary Prevention
There are no established measures for the secondary prevention of dermatofibroma.
References